Authors:
Monali Tayade, Sampada Kulkarni
Download free PDF
Veterinary 3D Printing Market Size & Share 2026-2035
Report ID: GMI13411
|
Published Date: November 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Veterinary 3D Printing Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
Veterinary 3D Printing Market Size
The veterinary 3D printing market was valued at USD 105 million in 2025 and is expected to reach USD 123 million in 2026, expanding at a 12.3% CAGR over the 2026–2035 forecast period to attain USD 349 million by 2035.
Veterinary 3D Printing Market Key Takeaways
Market Leader: Vimian led with over 11.1% market share in 2025.
Leading Players: Top 5 players in this market include Vimian, 3D Systems, WhiteClouds, OrthoDesigns, Med Dimensions, which collectively held a market share of 30.3% in 2025.
The veterinary 3D printing market is evolving from a specialist capability centered on complex orthopedic cases into a broader digital-care workflow spanning patient-specific implants, prosthetics, anatomical models, and surgical planning tools. Its commercial development depends on the growing availability of CT-derived design workflows, qualified materials, and specialty veterinary providers able to translate individualized device design into clinically usable products.
GMI Analyst View
Our engagement with veterinary device manufacturers and specialty practice operators indicates that the global veterinary 3D printing market generated approximately USD 65 million in 2022, underscoring the pace at which commercial adoption and technology integration have accelerated across veterinary specialty practices through the base year.
Veterinary 3D Printing Market Trends, Growth Drivers & GMI Forecast Outlook
Veterinary additive manufacturing is gaining relevance where anatomical variation makes standard devices less suitable, particularly in orthopedic reconstruction, rehabilitation, and pre-operative planning. Adoption is likely to remain led by referral hospitals and academic institutions until workflow standardization, practitioner capability, and in-house production economics improve further.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Companion animal populations provide the underlying clinical demand base for personalized orthopedic and reconstructive care. As owners pursue specialist interventions for conditions such as joint disease, limb deformities, and traumatic injury, the limitations of standardized implants become more visible. Patient-specific design gives surgeons a route to address breed-level and individual anatomical variability without relying exclusively on conventional catalog devices.
Procedure tracking also illustrates how orthopedic demand is becoming more formalized within specialist veterinary practice. The registry data point to a case environment in which surgical teams are increasingly able to identify, document, and refine treatment pathways for complex procedures [2]RCVS Knowledge. "National Canine Cruciate Surgery Registry Sees a 79% Increase in Surgeries Recorded in the Last Year." rcvsknowledge.org. This supports demand not only for definitive implants, but also for surgical guides and physical anatomical models that improve planning before the procedure begins.
Digital workflow maturity is equally important. A reliable CT-to-CAD-to-print process reduces friction between diagnostic imaging, implant design, and fabrication. As validated polymer and metal processing becomes more accessible, suppliers can address a wider range of load-bearing, reconstructive, and planning applications while reducing the dependence on bespoke manual design for every case.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Cost sensitivity constrains adoption where a conventional device or treatment pathway remains clinically acceptable. The value proposition for a customized solution is clearest in difficult reconstructive cases, but the incremental cost can remain difficult to justify for owners and practices addressing less complex conditions. This creates a practical separation between high-acuity referral work and broader general-practice demand.
The workforce challenge is not limited to surgical capability. Veterinary 3D printing also requires competence in image interpretation, digital design, material selection, quality assurance, and the integration of fabricated devices into clinical protocols. Where these capabilities are concentrated among a small number of advanced providers, the transfer of workflows into ordinary practice is necessarily gradual.
Capital requirements reinforce that concentration. Hospitals with sufficient case volume may justify in-house equipment and dedicated technical support, while smaller practices are more likely to use external service providers. Outsourcing lowers the initial investment burden, but it can add coordination and turnaround constraints that matter in time-sensitive surgical settings.
GMI Analyst View
We see the principal constraint as a diffusion problem rather than a clinical-validity problem. Patient-specific veterinary devices already carry a strong rationale in complex cases, but broader adoption will depend on whether outsourced and hybrid production models can make customization workable for practices without the capital base or multidisciplinary expertise of referral centers.
Veterinary 3D Printing Market Segment Analysis
By Product Type
Implants generated USD 43 million in 2025 and are projected to reach USD 157 million by 2035. Within the veterinary 3D printing market, this product category is anchored in patient-specific titanium and PEEK devices used for joint reconstruction, trauma management, spinal stabilization, and craniofacial procedures. Its importance stems from the clinical value of individualized geometry in anatomically variable, load-bearing applications.
Prosthetics and orthotics accounted for a 27.6% share in 2025 and are expected to expand at a 12.6% CAGR (2026-2035). Polymer-based additive manufacturing is especially relevant in this category because it supports lightweight, anatomy-matched devices for animals recovering from amputation, deformity, trauma, or mobility impairment. Scanning and digital fitting workflows can also reduce the level of manual adjustment required during production.
Anatomical models represented a 23.8% share in 2025 and are expected to generate USD 73 million by 2035. These models support surgical rehearsal, clinician communication, and veterinary training by giving teams a physical representation of an individual patient's anatomy. Their lower clinical-risk profile relative to implanted devices also makes them an important entry point for practices adopting 3D printing capabilities.
Other product types contribute through specialized dental, intraoral, and device-support applications, although demand remains more fragmented than in implants, prosthetics, and anatomical models.
By Animal Type
Companion animals generated USD 76 million in 2025 and are expected to grow at an 11.7% CAGR (2026-2035). The segment benefits from owner willingness to seek specialty care, rising use of referral pathways, and the broad range of orthopedic, dental, reconstructive, and rehabilitation conditions that can benefit from customized devices.
Livestock animals held a 27.6% share in 2025 and are projected to reach USD 108 million by 2035. Demand is concentrated in high-value animals, including breeding stock, performance horses, and selected bovine cases, where preserving mobility, productive capacity, or genetic value can justify customized treatment. The segment is growing at a faster rate than the companion animal segment through 2035.
By Application
Orthopedics generated USD 48 million in 2025 and is projected to grow at a 12.9% CAGR (2026-2035). The application benefits from a direct fit between additive manufacturing and the clinical challenge of matching implant geometry to variable animal anatomy. Surgical guides, anatomical models, and custom implants can work together in complex reconstructive procedures, making orthopedics a central commercial use case.
Surgical planning and training models held a 37.1% share in 2025 and are expected to generate USD 125 million by 2035. Their role extends from pre-operative rehearsal to veterinary education and skills development. Because these tools can be adopted before a practice commits to implantable-device workflows, they may help normalize additive manufacturing within specialty clinical operations.
Other applications include dental, craniofacial, and rehabilitation-related uses that expand the addressable clinical base while requiring different materials, design competencies, and approval pathways.
By Material
Metals generated USD 45 million in 2025 and are projected to hold a 47.0% share in 2035. Titanium-based additive manufacturing is particularly relevant for load-bearing orthopedic devices, where fatigue resistance, corrosion performance, and osseointegration influence long-term clinical utility. Metal printing remains technically demanding, which favors suppliers with established materials and quality-control expertise.
Ceramics held a 15.2% share in 2025 and are expected to generate USD 52 million by 2035. Their use is associated with applications in which chemical inertness, radiolucency, or bone-compatible surface characteristics are important. Improvements in ceramic printing and post-processing can expand relevance in veterinary dental and selected orthopedic applications.
Polymers accounted for a 32.4% share in 2025 and are projected to grow at an 11.7% CAGR (2026-2035). The segment serves prosthetics, orthotics, anatomical models, and selected structural applications. Its breadth reflects the availability of different polymer classes that can be selected for flexibility, durability, weight, imaging visibility, or biocompatibility.
By End Use
Veterinary hospitals and clinics generated USD 68 million in 2025 and are projected to grow at a 12.0% CAGR (2026-2035). Specialty hospitals and referral practices are the principal channel because they manage complex orthopedic and reconstructive cases and commonly operate the advanced imaging infrastructure needed for patient-specific digital design.
Academic and research institutions are expected to generate USD 95 million by 2035 and expand at a 14.0% CAGR (2026-2035). These institutions combine clinical demand with research, training, and materials-development activity. Their multi-application utilization of printing platforms can support experimentation with new device designs while building practitioner familiarity with digital clinical workflows.
Other end users participate through outsourced design, fabrication, and support models that can extend access to practices lacking their own printing infrastructure.
GMI Analyst View
We view anatomical models and surgical planning tools as the market's workflow-building layer. While implants carry substantial revenue importance, planning applications can establish the digital habits, imaging protocols, and clinician confidence that later support broader adoption of higher-value patient-specific devices.
Veterinary 3D Printing Market Regional Analysis
North America Veterinary 3D Printing Market Analysis
North America held a 42.9% share in 2025 and is projected to generate USD 122 million by 2035. The veterinary 3D printing market in the region is supported by established specialty hospital networks, advanced imaging access, and a mature companion-animal care environment. AVMA data indicate that 59.8 million U.S. households owned dogs in 2024, representing 45.5% of all U.S. households [1]American Veterinary Medical Association. "Pet Population Continues to Increase While Pet Spending Declines." avma.org.
United States
The United States generated USD 41 million in 2025 and is projected to reach USD 108 million by 2035. Its market position reflects the depth of specialty veterinary care, the presence of advanced referral centers, and the ability of multi-site hospital groups to invest in digital imaging, surgical planning, and customized device workflows. Commercial adoption is strengthened where providers can integrate design, fabrication, and surgical execution within a coordinated care pathway.
Canada
Canada is projected to generate USD 14 million by 2035 and grow at a 13.4% CAGR (2026-2035). Alignment with North American clinical standards and investment by academic veterinary centers support adoption. The market has particular potential where university and referral institutions serve as training and technology-transfer nodes for broader specialty practice.
Europe Veterinary 3D Printing Market Analysis
Europe generated USD 33 million in 2025 and is projected to hold a 33.2% share in 2035. The regional veterinary 3D printing market benefits from a large companion-animal base, established academic veterinary medicine, and a diverse network of specialist providers. Europe had approximately 306 million companion animals across roughly 140 million pet-owning households [3]FEDIAF. "European Pet Food Industry Report 2024." europeanpetfood.org.
Germany
Germany generated USD 9.5 million in 2025 and is projected to hold a 25.0% share within Europe by 2035. The country's precision-manufacturing capabilities and veterinary academic infrastructure provide favorable conditions for patient-specific implant development and digital surgical planning. Specialist hospitals and university clinics are positioned to translate this engineering capacity into clinical adoption.
United Kingdom
The United Kingdom held a 22.7% share within Europe in 2025 and is projected to grow at an 11.7% CAGR (2026-2035). Its referral sector and established orthopedic practice base support continued demand for surgical guides, anatomical models, and customized implants. The country's procedure-tracking ecosystem can also strengthen the evidence base for more standardized clinical workflows.
France
France is projected to generate USD 21 million by 2035 and grow at a 13.9% CAGR (2026-2035). Demand is supported by companion-animal care in urban markets and expanding specialist veterinary capacity. Academic centers and larger referral practices are likely to remain central to adoption because they can combine advanced imaging with specialist surgical expertise.
Italy
Italy is projected to generate USD 14 million by 2035 and grow at a 14.5% CAGR (2026-2035). The market is being supported by increasing care expectations among companion-animal owners and the potential for local materials and fabrication capabilities to serve orthopedic and planning applications. Adoption is likely to be strongest where specialty practices can demonstrate a clear clinical advantage over conventional devices.
Spain
Spain generated USD 2.8 million in 2025 and is projected to grow at a 14.3% CAGR (2026-2035). The country's expanding specialty veterinary sector creates a foundation for digital surgical planning and customized orthopedic applications. Cross-border access to European device suppliers can help providers adopt advanced workflows without developing every production capability internally.
Netherlands
The Netherlands is projected to generate USD 9.5 million by 2035 and grow at a 15.5% CAGR (2026-2035). Its dense life-science ecosystem, advanced university veterinary facilities, and strong trade connectivity support access to specialized materials and production technologies. These conditions can accelerate the transfer of additive-manufacturing capabilities from research and human-health settings into veterinary practice.
Asia Pacific Veterinary 3D Printing Market Analysis
Asia Pacific held a 17.1% share in 2025 and is projected to grow at a 15.9% CAGR (2026-2035). The veterinary 3D printing market is expanding as companion-animal care cultures mature, specialty infrastructure develops, and regional manufacturing capacity broadens across metals, polymers, and digital design services.
China
China generated USD 6.8 million in 2025 and is projected to hold a 38.6% share within Asia Pacific by 2035. Urban pet ownership, domestic additive-manufacturing capability, and the development of premium veterinary hospital chains support growth. The market is well positioned to connect local printing capacity with an expanding specialist referral base.
India
India is projected to generate USD 12 million by 2035 and grow at a 21.5% CAGR (2026-2035). Its growth outlook is supported by rising urban companion-animal ownership, developing specialty care infrastructure, and a competitive digital-design ecosystem. The country's livestock base adds a separate opportunity where customized devices can be justified for economically valuable animals.
Japan
Japan held a 25.0% share within Asia Pacific in 2025 and is projected to generate USD 16 million by 2035. The country combines a mature companion-animal care culture with deep precision-manufacturing expertise. Veterinary providers can leverage existing familiarity with imaging and customized-device workflows, particularly in small-animal orthopedics and dentistry.
Australia
Australia generated USD 2.0 million in 2025 and is projected to grow at a 15.6% CAGR (2026-2035). Its mix of companion-animal specialty practice and equine and livestock care provides several potential demand streams. Academic veterinary programs and specialist hospitals can play an important role in adapting additive manufacturing to local clinical needs.
South Korea
South Korea is projected to hold a 10.8% share within Asia Pacific by 2035 and grow at a 16.9% CAGR (2026-2035). The country's advanced materials and precision-manufacturing base supports veterinary device innovation as specialty hospital capacity expands. Demand is likely to favor urban companion-animal care settings where owners seek differentiated clinical outcomes.
Latin America Veterinary 3D Printing Market Analysis
Latin America generated USD 5 million in 2025 and is projected to reach USD 19 million by 2035. Growth in the veterinary 3D printing market is concentrated in major urban markets, where specialty veterinary services are developing alongside companion-animal ownership and premium care expectations.
Brazil
Brazil generated USD 2.2 million in 2025 and is projected to grow at a 13.9% CAGR (2026-2035). The country combines a substantial companion-animal population with established veterinary education and a significant livestock sector. This creates opportunities across small-animal orthopedic care as well as selected high-value equine and bovine applications.
Mexico
Mexico is projected to generate USD 4.5 million by 2035 and grow at a 12.5% CAGR (2026-2035). Demand is concentrated in metropolitan specialty practices serving owners with increasing expectations for advanced care. Proximity to the U.S. market may support technology transfer, supplier access, and exposure to established customized-device workflows.
Argentina
Argentina generated USD 0.8 million in 2025 and is projected to grow at a 15.5% CAGR (2026-2035). The market is supported by urban companion-animal care and a meaningful equine and agricultural base. Adoption will depend on whether specialist providers can develop commercially viable models for customized devices in both referral and high-value animal settings.
Middle East and Africa Veterinary 3D Printing Market Analysis
Middle East and Africa generated USD 4 million in 2025 and is projected to grow at a 6.7% CAGR (2026-2035). The regional veterinary 3D printing market remains at an earlier stage of development, with demand concentrated in higher-income markets that have more established specialty providers and premium companion-animal or equine care.
South Africa
South Africa generated USD 0.8 million in 2025 and is projected to reach USD 1.5 million by 2035. The country's established veterinary medicine system and mix of companion-animal, equine, and livestock demand provide a diversified base for customized orthopedic and planning applications. Growth will remain linked to specialist hospital investment and access to advanced fabrication services.
Saudi Arabia
Saudi Arabia held a 37.5% share within the region in 2025 and is projected to grow at a 7.2% CAGR (2026-2035). Premium companion-animal services and the economic importance of breeding and racing equines support demand for individualized care. The country's market is likely to favor high-value clinical cases in which customization offers a clear treatment or performance rationale.
UAE
The UAE is projected to generate USD 2.5 million by 2035 and grow at an 8.0% CAGR (2026-2035). Specialist hospital capacity in Dubai and Abu Dhabi, combined with the country's role as a regional medical-device distribution hub, supports access to advanced veterinary technologies. Commercial uptake will depend on the continued expansion of premium clinical services and qualified provider networks.
GMI Analyst View
We expect regional development to be determined less by animal ownership alone than by the ability to connect advanced imaging, design expertise, qualified fabrication, and specialty surgery in a dependable operating model. Asia Pacific's momentum is significant because it can pair expanding clinical demand with increasingly capable digital and manufacturing ecosystems.
Veterinary 3D Printing Market Share & Competitive Landscape
The veterinary 3D printing market share structure remains fragmented, with the top five participants collectively accounting for approximately 30.3% in 2025. The market's competitive intensity reflects the coexistence of broad additive-manufacturing platforms, veterinary device specialists, service bureaus, academic production centers, and regional providers that compete through clinical specialization, turnaround time, material capability, and referral relationships.
Vimian held an 11.1% share in 2025. Its veterinary medical technology portfolio spans orthopedics, surgical solutions, and dental devices, while its MedTech activities include the Movora orthopedics business [6]Vimian AB. "Annual Report 2024." vimian.com. This breadth can support integration with specialty hospital customers that require clinical credibility, device expertise, and dependable commercial support across multiple veterinary applications.
3D Systems held a 10.0% share in 2025. Its polymer and metal platform capabilities, healthcare-sector experience, and familiarity with patient-specific workflows create relevant advantages for veterinary applications such as anatomical models, surgical guides, and customized prosthetic components [7]3D Systems. "Annual Report 2024 / Form 10-K." 3dsystems.com. Its position illustrates the potential for established additive-manufacturing companies to apply proven technical infrastructure to veterinary demand.
WhiteClouds held a 3.3% share in 2025. Its service-bureau model can lower the entry barrier for practices that need customized anatomical models or prosthetic components but cannot justify in-house production. This outsourced approach is strategically important in a market where clinical demand may exist before individual hospitals have sufficient volume to support dedicated equipment and technical teams.
OrthoDesigns and Med Dimensions compete through specialized orthopedic and implant capabilities. In this part of the market, technical quality, clinical trust, and reliable production can create defensible positions even for focused providers. Competitors that can shorten the path from imaging to surgery while maintaining quality assurance are likely to be favored by referral practices managing complex cases.
Other participants include 3D Pets (DiveDesign LLC), bio3Dvet, CABIOMEDE Vet, Novus Life Sciences, Ortho Vet 3D, r3volutionD, and WIMBA. Their strategies span companion-animal prosthetics, biocompatible implant applications, biomedical research, orthopedic solutions, and digitally enabled orthotics. The diversity of these models indicates that the market has not yet converged on a single route to commercialization.
Recent Industry Developments
In October 2024, VCA Animal Hospitals opened a dedicated 3D Printing Lab for pet orthopedic surgery at VCA Northwest Veterinary Specialists in Clackamas, Oregon [4]PR Newswire. "VCA Animal Hospitals Launches 3D Printing Lab for Pet Orthopedic Surgeries." prnewswire.com. The facility supports patient-specific implants, surgical guides, and anatomical models based on CT-derived workflows. Its launch demonstrates how point-of-care additive manufacturing can move beyond academic and single-specialty settings into a multi-site hospital environment.
In October 2024, WIMBA opened an in-house 3D printing facility at its headquarters in Krakow, Poland [5]3DPrint.com. "WIMBA Opens New In-House 3D Printing Facility to Accelerate Pet Orthotics & Prosthetics." 3dprint.com. The company combines AI-assisted design, 3D scanning, and HP Multi Jet Fusion technology to produce custom orthotics and prosthetics for companion animals. The development reflects the growing commercial relevance of vertically integrated digital manufacturing for veterinary rehabilitation devices.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →